Teva launches generic version of PrAvelox


Teva’s Candian subsidiary, Eva Canada Limited, has announced that Health Canada has approved its application to produce a generic version of PrAvelox. The drug is used to treat adults who are suffering from respiratory tract infections, such as acute bacterial sinusitis, acute bacterial excerbations of chronic bronchitis, and mild to moderate community acquired pneumonia.

Read the source article at Yahoo! Finance

About the Author

Related Posts

Leave a Reply